Vanda Pharmaceuticals Inc. Financial Ratios — VNDA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-27.53	-131.94	-77.94	19.7	-27.13	-13.63	-11.85	12.39	33.67	5.4	6.92	1.22	0.47	-3.49	-50.93
Return on Assets (%)	-4.95	-17.99	-15.1	12.81	-20.72	-8.51	-7.49	9.38	28.33	4.59	5.88	1.02	0.39	-2.9	-38.51
Return on Capital (%)	- -	- -	- -	19.7	- -	- -	- -	12.39	- -	5.23	6.74	1.19	0.46	- -	- -
Return on Invested Capital (%)	- -	- -	- -	-56.17	- -	- -	- -	10.63	- -	4.5	6.71	0.67	-1.01	- -	- -
Gross Margin (%)	100	99.61	100	96.84	78.66	83.08	89.19	89.38	89.22	90.59	90.46	90.45	92.32	94.31	93.96
EBITDA Margin (%)	-27.96	-82.65	-56.89	-109.2	-24.23	-4.59	-8.43	12.79	11.31	12.13	16.75	3.56	-4.99	-15.53	-64.44
Operating Margin (%)	-34.24	-89.16	-62.58	-114.75	-36.56	-12.72	-10.24	11.26	10.04	10.98	15.69	2.49	-7.24	-20.46	-69.95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	137.83	3.15	21.11	72.76	250.6	- -	- -	- -
Pretax Margin (%)	-32.77	-87.44	-62.15	40.25	-36.27	-12.26	-9.35	13.12	12.78	12.76	15.77	4.44	3.29	-11.53	-64.16
Profit Margin (%)	-31.35	-87.44	-62.15	40.25	-36.27	-12.33	-9.43	13.05	50.86	9.4	12.34	2.47	1.3	-9.51	-102.02
Net Income to Common Margin (%)	-31.35	-87.44	-62.15	40.25	-36.27	-12.33	-9.43	13.05	50.86	9.4	12.34	2.47	1.3	-9.51	-102.02
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	0.54	- -	26.28	21.74	44.47	60.42	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-27.53	-131.94	-77.94	19.7	-27.13	-13.63	-11.85	12.39	33.67	5.4	6.92	1.22	0.47	-3.49	-50.93

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	15	14	12	11	9	12	13
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	2	2	4	6
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	12	11	10	9	7	8	7
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.57	0.45	0.27	1.23	-0.98	-0.4	-0.09
Net Debt/EBITDA	10.06	3.28	3.36	1.11	1.91	6.03	2.42	-2.47	-1.75	-2.03	-1.16	-14.9	14.12	3.32	0.61
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.64	0.5	0.29	1.76	-0.67	-0.3	-0.08
Net Debt/EBIT	8.21	3.04	3.05	1.06	1.27	2.18	1.99	-2.81	-1.98	-2.24	-1.23	-21.33	9.73	2.52	0.56
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	18.33	7.31	30.78	93.66	62.44	62.43	63.96	82.93	84.95	84.97	85.03	83.12	84.03	82.07	66.92
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.03	2.54	1.99	1.67	1.29	1.5	2.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.93	2.46	1.94	1.64	1.26	1.47	2.08
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.57	2.16	1.69	1.39	1.08	1.23	1.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.55	3	2.45	2.11	1.73	2.3	3.86
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.43	2.92	2.39	2.07	1.7	2.24	3.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.02	2.55	2.08	1.76	1.45	1.88	2.58
Net Debt to Equity	-262.66	-896.23	-146.78	-37.87	-38.22	-30.78	-25.59	-22.15	-10.97	-13.46	-10.31	-25.61	-24.93	-19	-25.93
Net Debt/Capital (%)	161.48	112.56	313.78	-60.95	-61.86	-44.47	-34.4	-28.45	-11.85	-15.04	-11.19	-33.48	-32.45	-22.81	-33.28
EBITDA	-9	-27	-19	-55	-27	-7	-14	25	26	30	45	9	-10	-31	-139
EBITDA-CapEx	-9	-29	-19	-64	-29	-8	-16	-1	25	28	44	8	-10	-31	-140
Operating Income (Loss)	-11	-29	-21	-58	-40	-19	-17	22	23	27	42	6	-14	-41	-151

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.71	3.73	3.97	16.67	2.79	2.81	2.04	4.85	5.25	5.58	5.82	5.11	4.43	3.75	1.82
Current Ratio	4.85	3.9	4.13	18.2	3.25	3.46	2.41	5.64	5.95	6.21	6.43	5.68	4.94	4.39	2.39
Quick Ratio	4.77	3.78	4.03	17.14	3.11	3.21	2.29	5.4	5.69	6.03	6.25	5.47	4.82	4.22	2.19
CFO/Avg Current Liab	-0.91	-1.41	-1.22	-4.01	0.42	-0.16	-0.03	0.49	0.82	0.83	0.92	0.39	0.14	-0.17	-0.89
Common Equity/Total Assets	18.33	7.31	30.78	93.66	62.44	62.43	63.96	82.93	84.95	84.97	85.03	83.12	84.03	82.07	66.92
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.03	2.54	1.99	1.67	1.29	1.5	2.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.93	2.46	1.94	1.64	1.26	1.47	2.08
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	2.57	2.16	1.69	1.39	1.08	1.23	1.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.55	3	2.45	2.11	1.73	2.3	3.86
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.43	2.92	2.39	2.07	1.7	2.24	3.71
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.02	2.55	2.08	1.76	1.45	1.88	2.58
CFO/Total Liabilities	-19.05	-35.78	-39.9	-749.1	15.56	-10.25	-2.68	52.88	63.11	64.57	72.26	29.88	12.36	-13.39	-67.66
CFO/CapEx	-103.31	-22.27	-224.95	-9.3	4.93	-5.76	-1.19	1.18	45.09	28.84	116.33	47.1	33.42	-32.16	-109.66
Altman's Z-Score	-0.76	-2.28	0.01	30.1	1.02	3.95	3.99	14.8	8	6.32	7.08	3.27	2.06	1.84	0.34

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	29.38	23.49	21.18	17.65	11	7.98	8.72	8.33	8.24	8.8	8.6	7.71	5.69	4.89	4.25
Days Sales Outstanding	12.43	15.54	17.23	20.69	33.18	45.74	41.86	43.83	44.3	41.48	42.45	47.33	64.11	74.6	85.87
Inventory Turnover	- -	4.53	- -	0.64	7.55	23.84	22.05	22.36	22.95	19.31	22.24	21.89	11.6	7.34	7.29
Days Inventory Outstanding	- -	80.64	- -	566.98	48.32	15.31	16.55	16.32	15.9	18.9	16.41	16.68	31.47	49.73	50.06
Accounts Payable Turnover	- -	0.29	-0.12	8.69	47.52	- -	- -	- -	- -	44.81	25.71	3.59	1.51	2.2	3.12
Accounts Payable Turnover Days	- -	1,258.86	-3,035.26	42	7.68	- -	- -	- -	- -	8.15	14.2	101.62	241.99	166.25	116.93
Cash Conversion Cycle	- -	-1,162.68	- -	545.67	73.82	61.05	58.42	60.15	60.2	52.24	44.67	-37.61	-146.42	-41.92	19
Inventory to Cash Days	- -	-65.1	- -	-546.3	-15.14	30.43	25.31	27.51	28.4	22.58	26.04	30.66	32.64	24.87	35.81
Inventories	- -	- -	- -	5	1	1	1	1	1	1	1	1	1	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	3	1	1	1	1	1	1	1	1	1	2	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	134	104	414	594	399	702	683	1,371	879	721	877	420	243	279	521
- Cash & Cash Equivalents	88	89	65	61	51	40	34	61	45	61	52	135	136	102	85
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	15	14	12	11	9	12	13
Enterprise Value	-15	-16	283	464	255	560	540	1,114	581	367	457	-36	-136	-83	270
Total Capital	33	10	44	161	133	131	131	275	426	467	517	538	554	551	340
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	3.43	2.92	2.39	2.07	1.7	2.24	3.71
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.03	0.04	0.03	-0.31	-0.07	-0.15	0.05
EV/Sales	- -	- -	8.36	9.26	2.32	3.84	3.27	5.77	2.56	1.48	1.7	- -	- -	- -	1.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	45.11	22.61	12.18	10.15	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	51.24	25.48	13.47	10.83	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	20.52	- -	- -	37.15	12.65	7.08	7.11	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	17.06	- -	- -	20.12	12.38	6.85	7.05	- -	- -	- -	- -
Diluted Market Cap	134	104	377	525	393	693	680	1,386	900	725	893	421	243	279	520
Diluted Enterprise Value	46	16	312	464	343	653	646	1,325	870	678	853	297	116	189	448
EV per Share	- -	- -	8.5	11.19	5.97	12.74	12.01	21.23	10.85	6.69	8.17	- -	- -	- -	4.57
TTM Sales	31	33	34	50	110	146	165	193	227	248	269	254	193	199	216
TTM EBITDA	-9	-27	-19	-55	-27	-7	-14	25	26	30	45	9	-10	-31	-139
TTM Operating Income	-11	-29	-21	-58	-40	-19	-17	22	23	27	42	6	-14	-41	-151
TTM Cash Flow to Firm	-28	-45	-40	-82	12	-8	-2	30	46	52	64	32	13	-16	-109
TTM Free Cash Flow to Firm	-28	-43	-39	-73	15	-7	- -	55	47	54	65	33	13	-15	-108

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-4.76	-2.43	-9.56	-7.22	26.27	-103.5	-2,131.58	25.04	19.16	13.54	13.79	12.89	18.42	-18.24	-4.79
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	51.24	25.48	13.47	10.83	- -	- -	- -	- -
Enterprise Value	-15	-16	283	464	255	560	540	1,114	581	367	457	-36	-136	-83	270
Low Price	4.33	2.92	3.57	8.34	8	6.91	11.9	13.75	11.83	7.12	13.14	6.73	3.3	3.46	3.81
EV/Sales	- -	- -	8.36	9.26	2.32	3.84	3.27	5.77	2.56	1.48	1.7	- -	- -	- -	1.25
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	45.11	22.61	12.18	10.15	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	24.67	- -	- -	- -	52.72	7.55	30.65	26.29	66.49	96.51	- -	- -
Price/Earnings Average	-18.98	-4.18	-11.42	22.58	-11.73	-28.67	-43.29	39.06	7.76	27.07	28.93	98.47	131.51	-14.89	-1.28
Price/Earnings High	-29.16	-5.4	-22.56	33.16	-15.9	-43.43	-54.57	67.47	14.39	39.55	36.63	152.29	186.39	-20.77	-2.57
Price/Earnings Low	-12.42	-2.88	-5.15	14.36	-8.48	-16.67	-34.2	27.74	5.44	16.61	22.01	60.56	75.36	-10.65	-1.02
Price/Book Value	4	10.55	9.38	3.69	3	5.34	5.2	4.98	2.14	1.59	1.74	0.8	0.45	0.52	1.59
Price/Book Value Average	5.56	12.09	5.99	3.38	3.56	3.98	5.15	3.69	2.2	1.4	1.91	1.18	0.61	0.52	0.87
Price/Book Value High	8.54	15.6	11.82	4.97	4.83	6.03	6.5	6.37	4.08	2.05	2.42	1.82	0.86	0.73	1.73
Price/Book Value Low	3.64	8.33	2.7	2.15	2.57	2.32	4.07	2.62	1.54	0.86	1.45	0.72	0.35	0.37	0.69
Price/Tangible Book Value	5.26	30.98	10.58	4.43	4.23	6.78	6.49	5.47	2.27	1.67	1.81	0.83	0.57	0.66	2.48
Price/Tangible Book Value Average	7.31	35.5	6.76	4.05	5.03	5.05	6.43	4.05	2.33	1.48	1.99	1.22	0.78	0.67	1.35
Price/Tangible Book Value High	11.24	45.8	13.35	5.96	6.81	7.65	8.1	6.99	4.32	2.16	2.52	1.89	1.11	0.93	2.7
Price/Tangible Book Value Low	4.78	24.45	3.04	2.58	3.63	2.94	5.08	2.88	1.63	0.9	1.51	0.75	0.45	0.48	1.07
Price/Sales	4.28	3.19	11.12	9.93	3.58	4.75	4.12	6.88	3.84	2.88	3.24	1.64	1.26	1.4	2.41
Price/Sales Average	5.95	3.66	7.1	9.09	4.26	3.54	4.08	5.1	3.95	2.55	3.57	2.43	1.71	1.42	1.31
Price/Sales High	9.14	4.72	14.02	13.35	5.77	5.36	5.15	8.81	7.32	3.72	4.52	3.76	2.43	1.97	2.62
Price/Sales Low	3.89	2.52	3.2	5.78	3.07	2.06	3.22	3.62	2.77	1.56	2.72	1.49	0.98	1.01	1.04
Price/Cash Flow	-4.71	-2.33	-9.51	-6.11	31.6	-85.53	-342.9	44.32	18.98	13.81	13.57	13.05	18.92	-17.68	-4.75
Price/Cash Flow Average	-6.55	-2.66	-6.07	-5.59	37.58	-63.72	-339.81	32.83	19.51	12.2	14.94	19.32	25.78	-17.87	-2.58
Price/Cash Flow High	-10.06	-3.44	-12	-8.21	50.91	-96.52	-428.4	56.72	36.2	17.83	18.91	29.88	36.53	-24.91	-5.17
Price/Cash Flow Low	-4.28	-1.84	-2.74	-3.55	27.15	-37.05	-268.46	23.32	13.68	7.48	11.36	11.88	14.77	-12.77	-2.05
Price/Free Cash Flow Average	-6.61	-2.79	-6.1	-6.61	31.24	-77.11	-2,112.39	18.55	19.7	11.96	15.17	19.09	25.1	-18.44	-2.61
Price/Free Cash Flow High	-10.16	-3.6	-12.05	-9.7	42.32	-116.8	-2,663.07	32.05	36.55	17.47	19.21	29.53	35.58	-25.71	-5.22
Price/Free Cash Flow Low	-4.33	-1.92	-2.75	-4.2	22.57	-44.84	-1,668.8	13.18	13.82	7.34	11.54	11.74	14.39	-13.18	-2.07
EV/Sales Average	3.14	0.95	5.88	9.63	3.85	3.3	3.9	4.94	3.84	2.37	3.44	1.96	1.06	0.97	0.98
EV/Sales High	6.33	2.01	13.49	14.71	5.38	5.15	4.97	8.77	7.24	3.56	4.4	3.29	1.78	1.53	2.29
EV/Sales Low	1.08	- -	1.6	5.68	2.65	1.81	3.04	3.42	2.65	1.38	2.59	1.02	0.33	0.56	0.71
EV/EBITDA Average	-11.23	-1.14	-10.34	-8.81	-15.89	-71.98	-46.22	38.67	33.97	19.58	20.56	54.9	-21.25	-6.23	-1.52
EV/EBITDA High	-22.65	-2.43	-23.71	-13.47	-22.21	-112.13	-58.89	68.59	64.03	29.34	26.27	92.38	-35.61	-9.84	-3.56
EV/EBITDA Low	-3.87	0.23	-2.82	-5.2	-10.95	-39.33	-36	26.75	23.46	11.4	15.43	28.5	-6.57	-3.62	-1.1
EV/EBIT Average	-9.17	-1.06	-9.4	-8.39	-10.53	-25.98	-38.06	43.92	38.28	21.64	21.95	78.61	-14.65	-4.73	-1.4
EV/EBIT High	-18.49	-2.25	-21.56	-12.82	-14.72	-40.47	-48.5	77.92	72.15	32.42	28.04	132.28	-24.55	-7.47	-3.28
EV/EBIT Low	-3.16	0.22	-2.56	-4.95	-7.26	-14.19	-29.65	30.39	26.44	12.6	16.47	40.81	-4.53	-2.75	-1.01
Last Price	4.76	3.7	12.41	14.32	9.31	15.95	15.2	26.13	16.41	13.14	15.69	7.39	4.22	4.79	8.82
High Price	10.17	5.47	15.65	19.25	15	18	18.99	33.44	31.3	16.96	21.86	16.92	8.15	6.75	9.6
Enterprise Value Average	98	31	199	483	423	482	643	955	873	589	925	498	204	192	211
Enterprise Value High	198	66	457	738	591	752	820	1,694	1,646	883	1,182	837	342	304	495
Enterprise Value Low	34	-6	54	285	292	264	501	661	603	343	695	258	63	112	153

Shares Outstanding	28	28	33	41	43	44	45	52	54	55	56	57	58	58	59
Diluted Weighted Avg Shares	28	28	30	37	42	43	45	53	55	55	57	57	58	58	59
Basic Weighted Avg Shares	28	28	30	35	42	43	45	51	53	54	56	56	57	58	59
Revenue per Share	1.11	1.16	1.12	1.44	2.6	3.36	3.69	3.8	4.28	4.56	4.84	4.51	3.36	3.42	3.67
EBITDA per Share	-0.31	-0.96	-0.63	-1.58	-0.63	-0.15	-0.31	0.49	0.48	0.55	0.81	0.16	-0.17	-0.53	-2.36
Operating Income per Share	-0.38	-1.03	-0.7	-1.66	-0.95	-0.43	-0.38	0.43	0.43	0.5	0.76	0.11	-0.24	-0.7	-2.57
Basic EPS, GAAP	-0.35	-1.01	-0.69	0.58	-0.94	-0.41	-0.35	0.5	2.17	0.43	0.6	0.11	0.04	-0.33	-3.74
Basic EPS from Cont Ops	-0.35	-1.01	-0.69	0.58	-0.94	-0.41	-0.35	0.5	2.17	0.43	0.6	0.11	0.04	-0.33	-3.74
Diluted EPS, GAAP	-0.35	-1.01	-0.69	0.55	-0.94	-0.41	-0.35	0.48	2.11	0.42	0.58	0.11	0.04	-0.33	-3.74
Diluted EPS from Cont Ops	-0.35	-1.01	-0.69	0.55	-0.94	-0.41	-0.35	0.48	2.11	0.42	0.58	0.11	0.04	-0.33	-3.74
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.01	-1.59	-1.3	-2.35	0.29	-0.19	-0.04	0.59	0.86	0.95	1.16	0.57	0.22	-0.27	-1.86
Free Cash Flow per Basic Share	-1.02	-1.66	-1.31	-2.6	0.23	-0.22	-0.08	0.09	0.85	0.92	1.15	0.55	0.22	-0.28	-1.87
Cash & Equivalents per Share	5.3	4.26	3.91	3.13	3.34	3.21	3.19	4.9	5.83	6.7	7.74	8.22	6.75	6.42	4.46
Book Value per Share	1.19	0.35	1.32	3.88	3.11	2.98	2.92	5.25	7.67	8.26	9.03	9.28	9.47	9.24	5.54
Tangible Book Value per Share	0.91	0.12	1.17	3.23	2.2	2.35	2.34	4.78	7.24	7.87	8.67	8.96	7.36	7.28	3.55

Vanda Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)